97049616
Sep 28, 2021
pharmaceutical preparations for the treatment of kidney disease; pharmaceutical preparations for the treatment of focal segmental glomerulosclerosis (FSGS); pharmaceutical preparations for the treatment of Immunoglobulin A Nephropathy (IgAN); pharmaceutical preparations for the treatment of Alport Syndrome; pharmaceutical preparations for the treatment of glomerulonephropathy; pharmaceutical preparations for the treatment of glomerulonephritis
Pharmaceuticals